Brisa S Fernandes

Publications

• Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis DOI: 10.1038/mp.2013.172
• The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies DOI: 10.1111/dmcn.12121
• Decreased peripheral brain-derived neurotrophic factor levels are not specific for bipolar disorder, major depressive disorder or schizophrenia: a meta-analysis
• Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force DOI: 10.1177/0004867413478217
• Reduced serum non-enzymatic antioxidant defense and increased lipid peroxidation in schizophrenic patients on a hypocaloric diet DOI: 10.1016/j.neulet.2012.01.060
• Minimum 2-year follow up of sex reassignment surgery in Brazilian male-to-female transsexuals DOI: 10.1111/j.1440-1819.2012.02342.x
• Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial DOI: 10.1186/1741-7015-10-91
• The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial DOI: 10.1016/j.jad.2011.06.005
• Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance DOI: 10.1590/s1516-44462011005000009
• Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance
• Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine (vol 70, pg 1416, 2009)
• HYPERSALIVATION ASSOCIATED WITH OLANZAPINE AND VALPROATE COMBINATION: A CASE REPORT DOI: 10.1017/S1092852912000223
• Decreased Peripheral Brain-derived Neurotrophic Factor Levels are Not Specific for Schizophrenia or Mood Disorders
• Decreased peripheral brain-derived neurotrophic factor levels are not specific for bipolar disorder, major depressive disorder or schizophrenia
• Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis DOI: 10.1016/j.jpsychires.2011.03.002
• Validity of the Portuguese version of the Bipolar Depression Rating Scale DOI: 10.1111/j.1601-5215.2010.00453.x
• Serum thiobarbituric acid reactive substances in bipolar disorder during mania and schizophrenia: a biomarker with possible diagnostic implications
• Serum Levels of II6, II10 and TNF-Alpha in Patients with Bipolar Disorder in Euthymia and with Schizophrenia: Differences in Pro and Anti-Inflammatory Balance
• Psychiatric hospitalizations due to bipolar disorder, major depression disorder, and schizophrenia in Rio Grande do Sul, Brazil
• Neurotrophin-3 is increased in patients with bipolar disorder on and off medication during manic and depressive episodes
• Lack of Association Between Serum Brain-Derived Neurotrophic Factor Levels and Improvement of Schizophrenia Symptoms in a Double-Blind, Randomized, Placebo-Controlled Trial of Memantine as Adjunctive Therapy to Clozapine DOI: 10.4088/JCP.09l05388
• Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes DOI: 10.1016/j.jpsychires.2009.11.020
• Improvement of schizophrenia with electroconvulsive therapy and serum brain-derived neurotrophic factor levels: Lack of association in a pilot study DOI: 10.1111/j.1440-1819.2010.02153.x
• Glutathione and redox biology in Bipolar Disorder; from pathophysiology to novel treatments
• Early life stress does not alter global DNA methylation in the striatum of an animal model of mania
• Correlation between serum brain-derived neurotrophic factor and neurotrophin-3 levels in bipolar disorder
• Complement system in bipolar disorders and schizophrenia: C3 and C4
• Comparison of cytokine levels in depressed, manic, and euthymic patients with bipolar disorder
• Cognitive assessment in a crack users population with and without mood disorders: a pilot study
• Brain-derived neutrotrophic in mania, depression, and euthymia in bipolar disorders: a systematic review and meta-analysis
• Brain-derived neurotrophic factor as a possible biomarker of bipolar disorder activity
• Biomarkers of Oxidative Stress in Chronic Stabilized Patients with Schizophrenia and Euthymic Patients with Bipolar Disorder
• The concept of staging in bipolar disorder: the role of BDNF and TNF-alpha as biomarkers DOI: 10.1111/j.1601-5215.2009.00410.x
• Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis DOI: 10.1016/j.jpsychires.2009.04.010
• Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients DOI: 10.1016/j.neulet.2009.02.032
• Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial
• Improvement of Schizophrenia Negative and Positive Symptoms With Memantine as Add-On Therapy to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial
• Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine DOI: 10.4088/JCP.08m04935gry
• Decreased Serum Brain-Derived Neurotrophic Factor in Unmedicated and Medicated Bipolar Patients in Manic and Depressive Episodes
• Decreased serum brain-derived neurotrophic factor in unmedicated and medicated bipolar patients during manic and depressive episodes
• Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients DOI: 10.1016/j.jpsychires.2009.04.002
• Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder DOI: 10.1016/j.jad.2008.12.001
• Brain-derived Neurotrophic Factor and Thiobarbituric Acid Reactive Substances Serum Levels in Chronicaly Medicated Schizophrenic Patients: A Positive Correlation
• The use of clozapine in the treatment of bipolar disorder in a patient with clinical comorbidities
• Psychological interventions for bipolar disorder reduces the recurrence of new episodes: a systematic review and meta-analysis
• Off-pump coronary artery bypass surgery does not reduce lymphocyte activation